Bristol-Myers still interested in buying innovative drugs, Bloomberg says Bristol-Myers will continue to target experimental treatments still in development, rather than commercial products that are already on the market, says Bloomberg. The drug company will focus on seeking out cancer treatments, added Bloomberg. Reference Link
News For BMY From The Last 14 Days
Check below for free stories on BMY the last two weeks.